Get the Stockscreener App
3.82
0.26%
0.0099
After Hours:
3.82
Regencell Bioscience Holdings Ltd stock is traded at $3.82, with a volume of 1,598.
It is up +0.26% in the last 24 hours and down -22.04% over the past month.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
See More
Previous Close:
$3.8101
Open:
$3.81
24h Volume:
1,598
Relative Volume:
0.03
Market Cap:
$49.71M
Revenue:
-
Net Income/Loss:
$-5.87M
P/E Ratio:
-8.4889
EPS:
-0.45
Net Cash Flow:
$-767.30K
1W Performance:
+1.06%
1M Performance:
-22.04%
6M Performance:
-53.19%
1Y Performance:
-51.77%
1-Day Range:
$3.81
$3.845
1-Week Range:
$3.63
$3.9899
52-Week Range:
$3.03
$32.44
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Compare RGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGC
Regencell Bioscience Holdings Ltd
|
3.82 | 49.71M | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Regencell Bioscience Holdings Ltd Stock (RGC) Latest News
Regencell Bioscience Extends Lock-Up Period for Stock Options - TipRanks
Regencell Bioscience Holdings Limited's (NASDAQ:RGC) most bullish insider is CEO Yat-Gai Au, and their holdings value went up by 74% last week - Simply Wall St
Regencell Bioscience Holdings (NASDAQ:RGC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
RGC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Regencell Bioscience (NASDAQ:RGC) Stock Quotes, Forecast and News Summary - Benzinga
Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish - Investing.com
Geron: Derisked And Highly Attractive After Approval (NASDAQ:GERN) - Seeking Alpha
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference - StockTitan
RBC says Regeneron reaction to biosimilar court ruling ‘overdone’ - TipRanks
Insider’s View: Deciphering Regenxbio Inc (RGNX)’s Financial Health Through Ratios - The Dwinnex
Xponance Inc. Lowers Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
40 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Itau Unibanco Holding S.A. - Defense World
Morse Asset Management Inc Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Regency Centers Co. (NASDAQ:REG) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ProShare Advisors LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Is Regenx Tech (CSE:RGX) Using Too Much Debt? - Simply Wall St
Benjamin F. Edwards & Company Inc. Purchases 612 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Profund Advisors LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Legacy Financial Advisors Inc. Purchases 69 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Ensign Peak Advisors Inc Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Ieq Capital LLC Purchases 507 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Trust Investment Advisors Acquires Shares of 192 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
ASB Consultores LLC Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
SYSTM Wealth Solutions LLC Sells 1,244 Shares of Regency Centers Co. (NASDAQ:REG) - Defense World
Intech Investment Management LLC Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
MRP Capital Investments LLC Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Meiji Yasuda Asset Management Co Ltd. Purchases 119 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Moors & Cabot Inc. Has $858,000 Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Wealth Alliance Sells 13 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Argent Trust Co Has $2.49 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Meiji Yasuda Life Insurance Co Sells 2,609 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Envestnet Asset Management Inc. - Defense World
Regency Centers (NASDAQ:REG) Stock Rating Lowered by Evercore ISI - Defense World
RGC’s 52-Week Rollercoaster: From $3.03 to $32.44 – What’s Next for Investors? - The InvestChronicle
Wall Street today: US stocks trade higher after promising inflation data raises Fed rate cut bets; 3M Co. gains 18.99% - Mint
Regencell Bioscience Holdings Limited's (NASDAQ:RGC) most bullish insider, CEO Yat-Gai Au must be pleased with the recent 321% gain - Yahoo Finance
United States shares lower at close of trade; Dow Jones Industrial Average down 0.14% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.14% - Investing.com
CPIX Stock Quote Price and Forecast - CNN
RGC Stock Quote Price and Forecast - CNN
Regencell Bioscience Holdings Limited (NASDAQ:RGC) CEO Yat-Gai Au's holdings dropped 16% in value as a result of the recent pullback - Yahoo Finance
Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation - Simply Wall St
15 Developed Countries with Lowest Autism Rates - Yahoo Finance
With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future - Yahoo Finance
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial - Business Wire
Game-Stop Or Game-On? RGC Has It All And Twice More - ValueWalk
Regencell Bioscience : Announces First Half 2022 Management Financial ResultsForm 6-K - Marketscreener.com
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO - Business Wire
RGC: Regencell BioscienceInvestigational Liquid-Formula RGC-COV19™ Shows Promise in Eliminating COVID-19 Symptoms - Yahoo Finance
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment - SEC.gov
Regencell Bioscience Holdings Ltd Stock (RGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):